UK government welcomes £300m AstraZeneca investment while urging refineries to maximise jet fuel output amid rising oil prices caused by a US‑Iran blockade

On 29 April 2026 the Prime Minister announced a surprise reversal by AstraZeneca to allocate £300 million to the United Kingdom’s life‑sciences sector, a move presented as a decisive boost to domestic pharmaceutical capabilities while, in the same breath, the government issued a directive to national refineries to increase their production of jet fuel in response to a sudden spike in crude prices linked to an American‑ordered blockade of Iran.

The investment, framed as a long‑term commitment to research, development and manufacturing within the UK, was described by officials as a strategic effort to reinforce the country’s position in the global biotech market, yet the timing coincides with Brent crude surging 1.8 per cent to exceed $113 a barrel, the highest level in a month and the highest since the end of March, a price movement directly attributed to reports that the United States, under President Trump, has instructed aides to prepare for an extended maritime blockade of Iranian shipping routes.

Faced with the geopolitical pressure that has already reduced the number of transits through the Strait of Hormuz to its lowest since the conflict began, the UK’s energy department has asked refining companies to maximise jet fuel output, a request that implicitly acknowledges the vulnerability of the nation’s aviation fuel supply chain to external shocks and highlights a policy paradox wherein the state simultaneously courts high‑tech investment and contends with the practical consequences of foreign‑driven energy volatility.

While officials argue that the dual announcements reflect a balanced approach to safeguarding economic growth and ensuring energy security, the juxtaposition of a lucrative pharma investment with a reactive measure to a foreign‑initiated oil price increase underscores a systemic reliance on unpredictable international actions, a reliance that critics may interpret as evidence of insufficient strategic foresight within the government’s broader economic planning framework.

Published: April 29, 2026